GB1063185A - Improvements in the administration of veterinary medicines - Google Patents
Improvements in the administration of veterinary medicinesInfo
- Publication number
- GB1063185A GB1063185A GB1771365A GB1771365A GB1063185A GB 1063185 A GB1063185 A GB 1063185A GB 1771365 A GB1771365 A GB 1771365A GB 1771365 A GB1771365 A GB 1771365A GB 1063185 A GB1063185 A GB 1063185A
- Authority
- GB
- United Kingdom
- Prior art keywords
- water
- vitamin
- medicament
- methyl
- polyalkylene glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
A method of administering veterinary medicines comprises administering a substantially water-free ointment comprising at least one medicament, at least one polyalkylene glycol or an ester or ether thereof, and at least one water-swellable substance to a mucous membrane of the oral cavity of an animal, e.g. the tongue. The polyalkylene glycol may be a polyethylene glycol having a M.W. between 200 and 20,000. The water-swellable substance may be a cellulose derivative, e.g. methyl-, ethyl- or carboxymethylcellulose, or pectin, agar, gelatin, gum tragacanth, or salts or esters of alginic acid. The ointment base may contain viscosity regulators e.g. glycerin, propylene glycol, wetting agents, and preservatives e.g. methyl p-oxybenzoate, phenyl mercury nitrate, or chlorocresol. The medicament may be an antibiotic (e.g. bacitracin or neomycin sulphate), a vitamin (e.g. vitamin E), an iron preparation (e.g. ferrous fumarate), dibromoxyquinoline, succinylsulphathiazole, piperazine adipate, lignocaine, or hexylresorcinol.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1771365A GB1063185A (en) | 1965-04-27 | 1965-04-27 | Improvements in the administration of veterinary medicines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1771365A GB1063185A (en) | 1965-04-27 | 1965-04-27 | Improvements in the administration of veterinary medicines |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1063185A true GB1063185A (en) | 1967-03-30 |
Family
ID=10099901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1771365A Expired GB1063185A (en) | 1965-04-27 | 1965-04-27 | Improvements in the administration of veterinary medicines |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1063185A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2085692A1 (en) * | 1970-03-10 | 1971-12-31 | Squibb & Sons Inc | |
WO1983003352A1 (en) * | 1982-03-30 | 1983-10-13 | Kvanta, Endre | Oral composition in the form of a combined iron-bacteria preparatrion particularly intended for treating animals |
EP0232877A2 (en) * | 1986-02-10 | 1987-08-19 | Zetachron, Inc. | Buccal drug dosage form |
EP0291838A3 (en) * | 1987-05-21 | 1989-05-31 | Squibb & Sons Inc | Oral drug delivery formulation and method for preparing same |
GR1003198B (en) * | 1998-09-04 | 1999-09-01 | Very volatile acetone concoction in liquid form | |
WO2004073597A2 (en) * | 2003-02-20 | 2004-09-02 | Reckitt Benckiser Healthcare (Uk) Limited | Bioadhesive liquid composition which is substancially free of water |
-
1965
- 1965-04-27 GB GB1771365A patent/GB1063185A/en not_active Expired
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2085692A1 (en) * | 1970-03-10 | 1971-12-31 | Squibb & Sons Inc | |
WO1983003352A1 (en) * | 1982-03-30 | 1983-10-13 | Kvanta, Endre | Oral composition in the form of a combined iron-bacteria preparatrion particularly intended for treating animals |
EP0232877A2 (en) * | 1986-02-10 | 1987-08-19 | Zetachron, Inc. | Buccal drug dosage form |
EP0232877A3 (en) * | 1986-02-10 | 1987-12-02 | Zetachron, Inc. | Buccal drug dosage form |
US4764378A (en) * | 1986-02-10 | 1988-08-16 | Zetachron, Inc. | Buccal drug dosage form |
EP0291838A3 (en) * | 1987-05-21 | 1989-05-31 | Squibb & Sons Inc | Oral drug delivery formulation and method for preparing same |
GR1003198B (en) * | 1998-09-04 | 1999-09-01 | Very volatile acetone concoction in liquid form | |
WO2004073597A2 (en) * | 2003-02-20 | 2004-09-02 | Reckitt Benckiser Healthcare (Uk) Limited | Bioadhesive liquid composition which is substancially free of water |
WO2004073597A3 (en) * | 2003-02-20 | 2004-11-11 | Reckitt Benckiser Healthcare | Bioadhesive liquid composition which is substancially free of water |
AU2004212746B2 (en) * | 2003-02-20 | 2010-03-25 | Reckitt Benckiser Healthcare (Uk) Limited | Bioadhesive liquid composition which is substantially free of water |
AU2004212746B8 (en) * | 2003-02-20 | 2010-04-15 | Reckitt Benckiser Healthcare (Uk) Limited | Bioadhesive liquid composition which is substantially free of water |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2321892A1 (en) | PHARMACEUTICAL PREPARATIONS FOR ORAL ADMINISTRATION CONTAINING NANDROLONE-17B ESTER AND NEW NANDROLONE-17B ESTERS | |
BE812909A (en) | IMPROVEMENTS IN OBTAINING MEDICINAL PREPARATIONS FOR ORAL ADMINISTRATION | |
ES321779A1 (en) | A method for developing pharmaceutical compositions. (Machine-translation by Google Translate, not legally binding) | |
DK156375C (en) | PREPARATIONS FOR ORAL ADMINISTRATION FOR DRUGS WITH LONG-TERM MEDICINAL DELIVERY | |
FR2523443B1 (en) | NOVEL PHARMACEUTICAL FORMULATIONS CONTAINING COENZYME Q10 SUITABLE FOR TOPICAL ADMINISTRATION | |
BE849632A (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
FI895482A0 (en) | The method prepares a topical medicated fluid for treating inflammation | |
IT1223290B (en) | VASOCINETIC ACTION POLYUNSATURATED ACIDS AND RELATED PHARMACEUTICAL AND COSMETIC FORMULATIONS | |
ES2117861T3 (en) | REDUCTION OF SKIN IRRITATION DURING THE ADMINISTRATION OF MEDICINES BY ELECTRIC TRANSPORT. | |
BE873973A (en) | METRONIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING | |
MY100647A (en) | Pharmaceuticals formulations. | |
GB1063185A (en) | Improvements in the administration of veterinary medicines | |
BE800695A (en) | PHARMACEUTICAL PREPARATIONS TO BE ADMINISTERED ORALLY CONTAINING AGGLUTININ | |
IT7849754A0 (en) | DEVICE FOR THE ADMINISTRATION OF MEDICINAL SUBSTANCES PARTICULARLY TO ANIMALS | |
GB1181673A (en) | Derivatives of Xanthen and Thiaxanthen and Preparation Thereof | |
SE382914B (en) | DEVICE FOR ADMINISTRATION OF MEDICINES IN FINE PREPARED POWDER | |
ES2033097T3 (en) | PROLONGED MEDICATION SUPPLY DEVICE FOR VETERINARY USE. | |
IE41287L (en) | Steroid pharmaceutical composition | |
BE842258A (en) | METHOD AND APPARATUS FOR ADMINISTERING ORAL MEDICINAL PRODUCTS | |
ES368325A1 (en) | Cephalosporius having a thioltherified methyl group in the 3-position | |
GB1268771A (en) | Azacarbazoles | |
BE758838A (en) | HETEROCYLIC CARBOXYLIC ACID ESTERS AND MEDICINAL PRODUCTS CONTAINING SUCH SUBSTANCES | |
GB843136A (en) | Improvements in and relating to pharmaceutical compositions | |
BE875932A (en) | NEW MEDICINAL PRODUCT, ESPECIALLY SEDATIVE AND SLEEP INDUCER AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
FR2287220A1 (en) | NEW ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION PROCESS |